170 related articles for article (PubMed ID: 36211430)
21. Elevated CD21
Bergman P; Wullimann D; Gao Y; Wahren Borgström E; Norlin AC; Lind Enoksson S; Aleman S; Ljunggren HG; Buggert M; Smith CIE
J Clin Immunol; 2022 May; 42(4):716-727. PubMed ID: 35290571
[TBL] [Abstract][Full Text] [Related]
22. COVID-19 in complex common variable immunodeficiency patients affected by lung diseases.
Milito C; Soccodato V; Auria S; Pulvirenti F; Quinti I
Curr Opin Allergy Clin Immunol; 2021 Dec; 21(6):535-544. PubMed ID: 34580250
[TBL] [Abstract][Full Text] [Related]
23. A beacon in the dark: COVID-19 course in CVID patients from two European countries: Different approaches, similar outcomes.
Milito C; Firinu D; Bez P; Villa A; Punziano A; Lagnese G; Costanzo G; van Leeuwen LPM; Piazza B; Deiana CM; d'Ippolito G; Del Giacco SR; Rattazzi M; Spadaro G; Quinti I; Scarpa R; Dalm VASH; Cinetto F
Front Immunol; 2023; 14():1093385. PubMed ID: 36845159
[TBL] [Abstract][Full Text] [Related]
24. Antibody response following the third and fourth SARS-CoV-2 vaccine dose in individuals with common variable immunodeficiency.
Nielsen BU; Drabe CH; Barnkob MB; Johansen IS; Hansen AKK; Nilsson AC; Rasmussen LD
Front Immunol; 2022; 13():934476. PubMed ID: 35967433
[TBL] [Abstract][Full Text] [Related]
25. Cellular immune response to SARS-CoV-2 in patients with primary antibody deficiencies.
Mizera D; Dziedzic R; Drynda A; Gradzikiewicz A; Jakieła B; Celińska-Löwenhoff M; Padjas A; Matyja-Bednarczyk A; Zaręba L; Bazan-Socha S
Front Immunol; 2023; 14():1275892. PubMed ID: 37901210
[TBL] [Abstract][Full Text] [Related]
26. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
[TBL] [Abstract][Full Text] [Related]
27. Cohort Profile:The Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 vaccines (ENFORCE).
Stærke NB; Reekie J; Johansen IS; Nielsen H; Benfield T; Wiese L; Søgaard OS; Tolstrup M; Iversen KK; Tarp B; Larsen FD; Larsen L; Lindvig SO; Holden IK; Iversen MB; Knudsen LS; Fogh K; Jakobsen ML; Traytel AK; Ostergaard L; Lundgren J;
BMJ Open; 2022 Dec; 12(12):e069065. PubMed ID: 36585137
[TBL] [Abstract][Full Text] [Related]
28. Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study.
Tan CY; Chiew CJ; Pang D; Lee VJ; Ong B; Lye DC; Tan KB
Lancet Infect Dis; 2023 Jul; 23(7):799-805. PubMed ID: 36924786
[TBL] [Abstract][Full Text] [Related]
29. SARS-COV-2 infections in inborn errors of immunity: A single center study.
Cousins K; DeFelice N; Jeong S; Feng J; Lee ASE; Rotella K; Sanchez D; Jaber F; Agarwal S; Ho HE; Cunningham-Rundles C
Front Immunol; 2022; 13():1035571. PubMed ID: 36479106
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 infection in pregnancy in Denmark-characteristics and outcomes after confirmed infection in pregnancy: A nationwide, prospective, population-based cohort study.
Aabakke AJM; Krebs L; Petersen TG; Kjeldsen FS; Corn G; Wøjdemann K; Ibsen MH; Jonsdottir F; Rønneberg E; Andersen CS; Sundtoft I; Clausen T; Milbak J; Burmester L; Lindved B; Thorsen-Meyer A; Khalil MR; Henriksen B; Jønsson L; Andersen LLT; Karlsen KK; Pedersen ML; Klemmensen Å; Vestgaard M; Thisted D; Tatla MK; Andersen LS; Brülle AL; Gulbech A; Andersson CB; Farlie R; Hansen L; Hvidman L; Sørensen AN; Rathcke SL; Rubin KH; Petersen LK; Jørgensen JS; Stokholm L; Bliddal M
Acta Obstet Gynecol Scand; 2021 Nov; 100(11):2097-2110. PubMed ID: 34467518
[TBL] [Abstract][Full Text] [Related]
31. Coronavirus disease 2019 in patients with inborn errors of immunity: An international study.
Meyts I; Bucciol G; Quinti I; Neven B; Fischer A; Seoane E; Lopez-Granados E; Gianelli C; Robles-Marhuenda A; Jeandel PY; Paillard C; Sankaran VG; Demirdag YY; Lougaris V; Aiuti A; Plebani A; Milito C; Dalm VA; Guevara-Hoyer K; Sánchez-Ramón S; Bezrodnik L; Barzaghi F; Gonzalez-Granado LI; Hayman GR; Uzel G; Mendonça LO; Agostini C; Spadaro G; Badolato R; Soresina A; Vermeulen F; Bosteels C; Lambrecht BN; Keller M; Mustillo PJ; Abraham RS; Gupta S; Ozen A; Karakoc-Aydiner E; Baris S; Freeman AF; Yamazaki-Nakashimada M; Scheffler-Mendoza S; Espinosa-Padilla S; Gennery AR; Jolles S; Espinosa Y; Poli MC; Fieschi C; Hauck F; Cunningham-Rundles C; Mahlaoui N; ; Warnatz K; Sullivan KE; Tangye SG
J Allergy Clin Immunol; 2021 Feb; 147(2):520-531. PubMed ID: 32980424
[TBL] [Abstract][Full Text] [Related]
32. Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study.
Xiong X; Lui DTW; Chung MSH; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Cheng FWT; Cheung CL; Chan EWY; Lee CH; Woo YC; Tan KCB; Wong CKH; Wong ICK
PLoS Med; 2023 Jul; 20(7):e1004274. PubMed ID: 37486927
[TBL] [Abstract][Full Text] [Related]
33. Easy approach to detect cell immunity to COVID vaccines in common variable immunodeficiency patients.
Barrios Y; Franco A; Alava-Cruz C; Cuesta-Martin R; Camara C; Matheu V
Allergol Immunopathol (Madr); 2022; 50(3):101-105. PubMed ID: 35527662
[TBL] [Abstract][Full Text] [Related]
34. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
[TBL] [Abstract][Full Text] [Related]
35. Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study.
Chemaitelly H; Ayoub HH; AlMukdad S; Coyle P; Tang P; Yassine HM; Al-Khatib HA; Smatti MK; Hasan MR; Al-Kanaani Z; Al-Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul-Rahim HF; Nasrallah GK; Al-Kuwari MG; Butt AA; Al-Romaihi HE; Al-Thani MH; Al-Khal A; Bertollini R; Abu-Raddad LJ
Lancet Microbe; 2022 Dec; 3(12):e944-e955. PubMed ID: 36375482
[TBL] [Abstract][Full Text] [Related]
36. CVID-Associated Tumors: Czech Nationwide Study Focused on Epidemiology, Immunology, and Genetic Background in a Cohort of Patients With CVID.
Kralickova P; Milota T; Litzman J; Malkusova I; Jilek D; Petanova J; Vydlakova J; Zimulova A; Fronkova E; Svaton M; Kanderova V; Bloomfield M; Parackova Z; Klocperk A; Haviger J; Kalina T; Sediva A
Front Immunol; 2018; 9():3135. PubMed ID: 30723478
[No Abstract] [Full Text] [Related]
37. SARS-CoV-2-Specific and Functional Cytotoxic CD8 Cells in Primary Antibody Deficiency: Natural Infection and Response to Vaccine.
Gupta S; Agrawal S; Sandoval A; Su H; Tran M; Demirdag Y
J Clin Immunol; 2022 Jul; 42(5):914-922. PubMed ID: 35366743
[TBL] [Abstract][Full Text] [Related]
38. Experience with sotrovimab treatment of SARS-CoV-2-infected patients in Denmark.
Rasmussen LD; Lebech AM; Øvrehus A; Poulsen BK; Christensen HR; Nielsen H; Johansen IS; Omland LH; Wiese L; Helleberg M; Storgaard M; Dalager-Pedersen M; Rasmussen TA; Benfield T; Petersen TS; Andersen ÅB; Gram MA; Stegger M; Edslev SM; Obel N
Br J Clin Pharmacol; 2023 Jun; 89(6):1820-1833. PubMed ID: 36519217
[TBL] [Abstract][Full Text] [Related]
39. COMMON VARIABLE IMMUNODEFICIENCY: PREDISPOSING OR PROTECTIVE FACTOR FOR SEVERE COMPLICATIONS OF COVID-19?
Ferenc T; Vilibić-Čavlek T
Acta Clin Croat; 2022 Mar; 61(1):107-114. PubMed ID: 36398083
[TBL] [Abstract][Full Text] [Related]
40. SARS-CoV-2 Infection and Postacute Risk of Non-Coronavirus Disease 2019 Infectious Disease Hospitalizations: A Nationwide Cohort Study of Danish Adults Aged ≥50 Years.
Andersson NW; Thiesson EM; Lassaunière R; Hansen JV; Hviid A
Clin Infect Dis; 2024 Mar; 78(3):603-612. PubMed ID: 37740392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
